Key Insights

Highlights

Treatment Research

2 treatments under study, led by Peterio

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown2

Clinical Trials (2)

Research Network

Common Treatments

  • Peterio1
  • Ipl Quantum Product Manufactured By Luminis Ltd1

Active Sponsors

  • Rambam Health Care Campus1
  • Scilex Ltd.1
  • Lumenis Be Ltd.1

Top Investigators

Related Conditions

  • Hirsutism1
  • Hypertrichosis1
  • Rhytides1
  • Port Wine Stain1

Activity Timeline